RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets pancreatic cancer before surgery
Disease control OngoingThis early-phase trial tests a drug called ivosidenib combined with standard chemotherapy in people with pancreatic cancer that can be surgically removed. The goal is to find the safest dose and see if the combination shrinks tumors before surgery. Up to 16 participants will take…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Biomarker may guide chemo choices for pancreatic cancer patients
Knowledge-focused OngoingThis study looks at whether a biomarker called GATA6 can help predict how well chemotherapy works for people with pancreatic cancer that can be surgically removed. About 84 participants will receive chemotherapy before and after surgery, and researchers will measure their GATA6 l…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 18, 2026 12:11 UTC